Quick Answer
P3 Health Partners Inc. reported Diluted EPS of $45.26 per share (loss) for fiscal year 2025.
P3 Health Partners Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$45.26 | +16.3% |
| 2024 | -$54.06 | -8481.0% |
| 2023 | -$0.63 | +90.3% |
| 2022 | -$6.50 | -2608.3% |
| 2021 | -$0.24 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$9.67 | +38.4% | -55.2% |
| June 30, 2025 | -$6.23 | +15.5% | +0.8% |
| March 31, 2025 | -$6.28 | +20.1% | +60.0% |
| September 30, 2024 | -$15.70 | -12983.3% | -113.0% |
| June 30, 2024 | -$7.37 | -8088.9% | +6.2% |
| March 31, 2024 | -$7.86 | -3472.7% | -6450.0% |
| September 30, 2023 | -$0.12 | +55.6% | -33.3% |
| June 30, 2023 | -$0.09 | +97.6% | +59.1% |
- P3 Health Partners Inc. showed an increase of +16.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, P3 Health Partners Inc.’s diluted eps has declined by 18758.3% (from $0.24 per share (loss) to $45.26 per share (loss)).
- The most recent figure is from P3 Health Partners Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: